Corium to Present at the 2018 Cantor Fitzgerald Global Heathcare Conference
MENLO PARK, Calif. , Sept. 24, 2018 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple , Corium’s President and…